CARsgen Therapeutics

CARsgen Therapeutics is a leading immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach, and brain cancers. They have partnerships with the Shanghai Cancer Institute and Shanghai Renji Hospital. CARsgen has achieved significant milestones in CAR-T development, including completing the world's first hepatocellular carc...